Donation

ONS 2020 header image

As part of the Oncology Nurses Society’s ONS Bridge Event, the International Myeloma Foundation hosted a virtual symposium New Strategies for Multiple Myeloma Care: Case Studies for Nurses in September, 2020. Four highly experienced nurses shared their expertise using real-life patient case scenarios.

We invite you to view the symposium (no credit), download free slides, or earn up to 1.5 CNE credits.  

Co-Chairs: Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN; Joseph D. Tariman, PhD, RN, ANP-BC, FAAN
Faculty: Amy E. Pierre, RN, MSN, ANP-BC; Tiffany Richards, PhD, ANP-BC, AOCNP®


Part 1: Newly Diagnosed Multiple Myeloma
CNE

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN;
Joseph D. Tariman, PhD, RN, ANP-BC, FAAN  
  
Release Date: August 18, 2020
Expiration Date: August 18, 2021

This activity on newly diagnosed multiple myeloma will include an overview of the disease, as well as current treatment workup and testing recommendations for multiple myeloma. Through the cases of June and Lisa, our faculty will explore transplant eligibility, induction, and maintenance therapy. Please remember to complete part 2 and 3 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.

Download Slides

Begin, Earn Credit   View Only, No Credit

 

preview

Part 2: Relapsed Multiple Myeloma
CNE

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN;
Amy E. Pierre, RN, MSN, ANP-BC
   
Release Date: August 18, 2020
Expiration Date: August 18, 2021

This activity on relapsed multiple myeloma will include some recently approved drugs and dosage forms. Through the cases of Steve and Michelle, our faculty will review treatment considerations in the cases of early relapsed patients. Please remember to complete part 1 and 3 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.

Download Slides

Begin, Earn Credit   View Only, No Credit

 

preview

Part 3: Heavily Pretreated Multiple Myeloma and Drugs in Development
CNE

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN;
Tiffany Richards, PhD, ANP-BC, AOCNP®
 
Release Date: August 18, 2020
Expiration Date: August 18, 2021

This activity will focus on heavily pretreated multiple myeloma and drugs in development. Through the case of Carl, a patient who has received several multiple myeloma therapies over his 10-year history with the disease, our faculty will discuss clinical trial participation, and drugs in development. Please remember to complete part 1 and 2 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.

Download Slides

Begin, Earn Credit   View Only, No Credit

 

preview

Provided by the International Myeloma Foundation

Accredited by Annenberg Center for Health Sciences at Eisenhower

This activity is supported by educational grants from Bristol Myers Squibb (formerly Celgene); GlaxoSmithKline; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics Inc.; Oncopeptides, Inc.; Sanofi Genzyme; and Takeda Oncology.

 

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.